Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1995 Sep;69(9):5252–5260. doi: 10.1128/jvi.69.9.5252-5260.1995

Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication.

M Pope 1, O Rotstein 1, E Cole 1, S Sinclair 1, R Parr 1, B Cruz 1, R Fingerote 1, S Chung 1, R Gorczynski 1, L Fung 1, et al.
PMCID: PMC189358  PMID: 7636967

Abstract

Murine hepatitis virus strain (MHV-3) produces a strain-dependent pattern of disease which has been used as a model for fulminant viral hepatitis. This study was undertaken to examine whether there was a correlation between macrophage activation and susceptibility or resistance to MHV-3 infection. Peritoneal macrophages were isolated from resistant A/J and susceptible BALB/cJ mice and, following stimulation with MHV-3 or lipopolysaccharide (LPS), analyzed for transcription of mRNA and production of interleukin-1 (IL-1), tumor necrosis factor alpha (TNF-alpha), transforming growth factor beta (TGF-beta), mouse fibrinogen-like protein (musfiblp), tissue factor (TF), leukotriene B4, and prostaglandin E2 (PGE2). Macrophages from BALB/cJ mice produced greater amounts of IL-1, TNF-alpha, TGF-beta, leukotriene B4, and musfiblp following MHV-3 infection than macrophages from resistant A/J mice, whereas in response to LPS, equivalent amounts of IL-1, TNF-alpha, TGF-beta, and TF were produced by macrophages from both strains of mice. Levels of mRNA of IL-1, TNF-alpha, and musfiblp were greater and more persistent in BALB/cJ than in A/J macrophages, whereas the levels and kinetics of IL-1, TNF-alpha, and TF mRNA following LPS stimulation were identical in macrophages from both strains of mice. Levels of production of PGE2 by MHV-3-stimulated macrophages from resistant and susceptible mice were equivalent; however, the time course for induction of PGE2, differed, but the total quantity of PGE2 produced was insufficient to inhibit induction of musfiblp, a procoagulant known to correlate with development of fulminant hepatic necrosis in susceptible mice. These results demonstrate marked differences in production of inflammatory mediators to MHV-3 infection in macrophages from resistant A/J and susceptible BALB/cJ mice, which may explain the marked hepatic necrosis and fibrin deposition and account for the lethality of MHV-3 in susceptible mice.

Full Text

The Full Text of this article is available as a PDF (459.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abecassis M., Falk J. A., Makowka L., Dindzans V. J., Falk R. E., Levy G. A. 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest. 1987 Sep;80(3):881–889. doi: 10.1172/JCI113147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Akama H. Involvement of tumor necrosis factor alpha in experimentally induced hepatitis. Gastroenterology. 1991 Apr;100(4):1153–1154. doi: 10.1016/0016-5085(91)90309-9. [DOI] [PubMed] [Google Scholar]
  3. Arnstein H. R., Cox R. A. Isolation of nucleic acids. Br Med Bull. 1966 May;22(2):158–163. doi: 10.1093/oxfordjournals.bmb.a070459. [DOI] [PubMed] [Google Scholar]
  4. Arthur M. J., Bentley I. S., Tanner A. R., Saunders P. K., Millward-Sadler G. H., Wright R. Oxygen-derived free radicals promote hepatic injury in the rat. Gastroenterology. 1985 Nov;89(5):1114–1122. doi: 10.1016/0016-5085(85)90218-5. [DOI] [PubMed] [Google Scholar]
  5. Arthur M. J., Kowalski-Saunders P., Wright R. Effect of endotoxin on release of reactive oxygen intermediates by rat hepatic macrophages. Gastroenterology. 1988 Dec;95(6):1588–1594. doi: 10.1016/s0016-5085(88)80082-9. [DOI] [PubMed] [Google Scholar]
  6. Bang F. B., Warwick A. MOUSE MACROPHAGES AS HOST CELLS FOR THE MOUSE HEPATITIS VIRUS AND THE GENETIC BASIS OF THEIR SUSCEPTIBILITY. Proc Natl Acad Sci U S A. 1960 Aug;46(8):1065–1075. doi: 10.1073/pnas.46.8.1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Beutler B., Krochin N., Milsark I. W., Luedke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 1986 May 23;232(4753):977–980. doi: 10.1126/science.3754653. [DOI] [PubMed] [Google Scholar]
  8. Bevilacqua M. P., Pober J. S., Majeau G. R., Cotran R. S., Gimbrone M. A., Jr Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984 Aug 1;160(2):618–623. doi: 10.1084/jem.160.2.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bevilacqua M. P., Pober J. S., Majeau G. R., Fiers W., Cotran R. S., Gimbrone M. A., Jr Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533–4537. doi: 10.1073/pnas.83.12.4533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brown P. D., Wakefield L. M., Levinson A. D., Sporn M. B. Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors. 1990;3(1):35–43. doi: 10.3109/08977199009037500. [DOI] [PubMed] [Google Scholar]
  11. Caput D., Beutler B., Hartog K., Thayer R., Brown-Shimer S., Cerami A. Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1670–1674. doi: 10.1073/pnas.83.6.1670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chung S. W., Sinclair S. B., Fung L. S., Cole E. H., Levy G. A. Effect of eicosanoids on induction of procoagulant activity by murine hepatitis virus strain 3 in vitro. Prostaglandins. 1991 Dec;42(6):501–513. doi: 10.1016/0090-6980(91)90013-6. [DOI] [PubMed] [Google Scholar]
  13. Chung S., Gorczynski R., Cruz B., Fingerote R., Skamene E., Perlman S., Leibowitz J., Fung L., Flowers M., Levy G. A Th1 cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity in vitro and protects against MHV-3 mortality in vivo. Immunology. 1994 Nov;83(3):353–361. [PMC free article] [PubMed] [Google Scholar]
  14. Danielpour D., Dart L. L., Flanders K. C., Roberts A. B., Sporn M. B. Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture. J Cell Physiol. 1989 Jan;138(1):79–86. doi: 10.1002/jcp.1041380112. [DOI] [PubMed] [Google Scholar]
  15. Demers L. M., Derck D. D. A radioimmunoassay for 6-keto-prostaglandin F1 alpha. Adv Prostaglandin Thromboxane Res. 1980;6:193–199. [PubMed] [Google Scholar]
  16. Dindzans V. J., MacPhee P. J., Fung L. S., Leibowitz J. L., Levy G. A. The immune response to mouse hepatitis virus: expression of monocyte procoagulant activity and plasminogen activator during infection in vivo. J Immunol. 1985 Dec;135(6):4189–4197. [PubMed] [Google Scholar]
  17. Dindzans V. J., Skamene E., Levy G. A. Susceptibility/resistance to mouse hepatitis virus strain 3 and macrophage procoagulant activity are genetically linked and controlled by two non-H-2-linked genes. J Immunol. 1986 Oct 1;137(7):2355–2360. [PubMed] [Google Scholar]
  18. Dindzans V. J., Zimmerman B., Sherker A., Levy G. A. Susceptibility to mouse hepatitis virus strain 3 in BALB/cJ mice: failure of immune cell proliferation and interleukin 2 production. Adv Exp Med Biol. 1987;218:411–420. doi: 10.1007/978-1-4684-1280-2_50. [DOI] [PubMed] [Google Scholar]
  19. Dixon R. A., Diehl R. E., Opas E., Rands E., Vickers P. J., Evans J. F., Gillard J. W., Miller D. K. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature. 1990 Jan 18;343(6255):282–284. doi: 10.1038/343282a0. [DOI] [PubMed] [Google Scholar]
  20. Fan S. T., Edgington T. S. Clonal analysis of mechanisms of murine T helper cell collaboration with effector cells of macrophage lineage. J Immunol. 1988 Sep 15;141(6):1819–1827. [PubMed] [Google Scholar]
  21. Fung L. S., Neil G., Leibowitz J., Cole E. H., Chung S., Crow A., Levy G. A. Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection. J Biol Chem. 1991 Jan 25;266(3):1789–1795. [PubMed] [Google Scholar]
  22. Gallily R., Warwick A., Bang F. B. Ontogeny of macrophage resistance to mouse hepatitis in vivo and in vitro. J Exp Med. 1967 Apr 1;125(4):537–548. doi: 10.1084/jem.125.4.537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Geerts A., Schellinck P., Bouwens L., Wisse E. Cell population kinetics of Kupffer cells during the onset of fibrosis in rat liver by chronic carbon tetrachloride administration. J Hepatol. 1988 Feb;6(1):50–56. doi: 10.1016/s0168-8278(88)80461-6. [DOI] [PubMed] [Google Scholar]
  24. Glisin V., Crkvenjakov R., Byus C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry. 1974 Jun 4;13(12):2633–2637. doi: 10.1021/bi00709a025. [DOI] [PubMed] [Google Scholar]
  25. Hagmann W., Steffan A. M., Kirn A., Keppler D. Leukotrienes as mediators in frog virus 3-induced hepatitis in rats. Hepatology. 1987 Jul-Aug;7(4):732–736. doi: 10.1002/hep.1840070419. [DOI] [PubMed] [Google Scholar]
  26. Hilton A., Mizzen L., MacIntyre G., Cheley S., Anderson R. Translational control in murine hepatitis virus infection. J Gen Virol. 1986 May;67(Pt 5):923–932. doi: 10.1099/0022-1317-67-5-923. [DOI] [PubMed] [Google Scholar]
  27. Kehrl J. H., Wakefield L. M., Roberts A. B., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M. B., Fauci A. S. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986 May 1;163(5):1037–1050. doi: 10.1084/jem.163.5.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Koyama T., Hall L. R., Haser W. G., Tonegawa S., Saito H. Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains. Proc Natl Acad Sci U S A. 1987 Mar;84(6):1609–1613. doi: 10.1073/pnas.84.6.1609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Krzystyniak K., Dupuy J. M. Early interaction between mouse hepatitis virus 3 and cells. J Gen Virol. 1981 Nov;57(Pt 1):53–61. doi: 10.1099/0022-1317-57-1-53. [DOI] [PubMed] [Google Scholar]
  30. Kunkel S. L., Wiggins R. C., Chensue S. W., Larrick J. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem Biophys Res Commun. 1986 May 29;137(1):404–410. doi: 10.1016/0006-291x(86)91224-6. [DOI] [PubMed] [Google Scholar]
  31. Lamontagne L., Descoteaux J. P., Jolicoeur P. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity. J Immunol. 1989 Jun 15;142(12):4458–4465. [PubMed] [Google Scholar]
  32. Laskin D. L. Nonparenchymal cells and hepatotoxicity. Semin Liver Dis. 1990 Nov;10(4):293–304. doi: 10.1055/s-2008-1040485. [DOI] [PubMed] [Google Scholar]
  33. Lee W. M. Acute liver failure. N Engl J Med. 1993 Dec 16;329(25):1862–1872. doi: 10.1056/NEJM199312163292508. [DOI] [PubMed] [Google Scholar]
  34. Levy G. A., Leibowitz J. L., Edgington T. S. Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med. 1981 Oct 1;154(4):1150–1163. doi: 10.1084/jem.154.4.1150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Li C., Fung L. S., Chung S., Crow A., Myers-Mason N., Phillips M. J., Leibowitz J. L., Cole E., Ottaway C. A., Levy G. Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection. J Exp Med. 1992 Sep 1;176(3):689–697. doi: 10.1084/jem.176.3.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lomedico P. T., Gubler U., Hellmann C. P., Dukovich M., Giri J. G., Pan Y. C., Collier K., Semionow R., Chua A. O., Mizel S. B. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. 1984 Nov 29-Dec 5Nature. 312(5993):458–462. doi: 10.1038/312458a0. [DOI] [PubMed] [Google Scholar]
  37. MacPhee P. J., Dindzans V. J., Fung L. S., Levy G. A. Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3. Hepatology. 1985 Jul-Aug;5(4):649–660. doi: 10.1002/hep.1840050422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Mackman N., Brand K., Edgington T. S. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med. 1991 Dec 1;174(6):1517–1526. doi: 10.1084/jem.174.6.1517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Mackman N., Morrissey J. H., Fowler B., Edgington T. S. Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry. 1989 Feb 21;28(4):1755–1762. doi: 10.1021/bi00430a050. [DOI] [PubMed] [Google Scholar]
  40. Macnaughton M. R., Patterson S. Mouse hepatitis virus strain 3 infection of C57, A/Sn and A/J strain mice and their macrophages. Brief report. Arch Virol. 1980;66(1):71–75. doi: 10.1007/BF01315046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. McClain C. J., Cohen D. A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology. 1989 Mar;9(3):349–351. doi: 10.1002/hep.1840090302. [DOI] [PubMed] [Google Scholar]
  42. Miller D. K., Gillard J. W., Vickers P. J., Sadowski S., Léveillé C., Mancini J. A., Charleson P., Dixon R. A., Ford-Hutchinson A. W., Fortin R. Identification and isolation of a membrane protein necessary for leukotriene production. Nature. 1990 Jan 18;343(6255):278–281. doi: 10.1038/343278a0. [DOI] [PubMed] [Google Scholar]
  43. Mizel S. B., Oppenheim J. J., Rosenstreich D. L. Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes. J Immunol. 1978 May;120(5):1497–1503. [PubMed] [Google Scholar]
  44. Muñoz S. J. Difficult management problems in fulminant hepatic failure. Semin Liver Dis. 1993 Nov;13(4):395–413. doi: 10.1055/s-2007-1007368. [DOI] [PubMed] [Google Scholar]
  45. Nawroth P. P., Stern D. M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med. 1986 Mar 1;163(3):740–745. doi: 10.1084/jem.163.3.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Parr R. L., Fung L., Reneker J., Myers-Mason N., Leibowitz J. L., Levy G. Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity. J Virol. 1995 Aug;69(8):5033–5038. doi: 10.1128/jvi.69.8.5033-5038.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Ranganathan G., Blatti S. P., Subramaniam M., Fass D. N., Maihle N. J., Getz M. J. Cloning of murine tissue factor and regulation of gene expression by transforming growth factor type beta 1. J Biol Chem. 1991 Jan 5;266(1):496–501. [PubMed] [Google Scholar]
  48. Salmon J. A., Simmons P. M., Palmer R. M. A radioimmunoassay for leukotriene B4. Prostaglandins. 1982 Aug;24(2):225–235. doi: 10.1016/0090-6980(82)90148-4. [DOI] [PubMed] [Google Scholar]
  49. Schindler R., Clark B. D., Dinarello C. A. Dissociation between interleukin-1 beta mRNA and protein synthesis in human peripheral blood mononuclear cells. J Biol Chem. 1990 Jun 25;265(18):10232–10237. [PubMed] [Google Scholar]
  50. Shif I., Bang F. B. In vitro interaction of mouse hepatitis virus and macrophages from genetically resistant mice. I. Adsorption of virus and growth curves. J Exp Med. 1970 Apr 1;131(4):843–850. doi: 10.1084/jem.131.4.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Shiratori Y., Takikawa H., Kawase T., Sugimoto T. Superoxide anion generating capacity and lysosomal enzyme activities of Kupffer cells in galactosamine induced hepatitis. Gastroenterol Jpn. 1986 Apr;21(2):135–144. doi: 10.1007/BF02774831. [DOI] [PubMed] [Google Scholar]
  52. Sporn M. B., Roberts A. B., Wakefield L. M., de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol. 1987 Sep;105(3):1039–1045. doi: 10.1083/jcb.105.3.1039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Stern D. M., Bank I., Nawroth P. P., Cassimeris J., Kisiel W., Fenton J. W., 2nd, Dinarello C., Chess L., Jaffe E. A. Self-regulation of procoagulant events on the endothelial cell surface. J Exp Med. 1985 Oct 1;162(4):1223–1235. doi: 10.1084/jem.162.4.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Thornberry N. A., Bull H. G., Calaycay J. R., Chapman K. T., Howard A. D., Kostura M. J., Miller D. K., Molineaux S. M., Weidner J. R., Aunins J. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 1992 Apr 30;356(6372):768–774. doi: 10.1038/356768a0. [DOI] [PubMed] [Google Scholar]
  55. Wedmore C. V., Williams T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981 Feb 19;289(5799):646–650. doi: 10.1038/289646a0. [DOI] [PubMed] [Google Scholar]
  56. Winwood P. J., Arthur M. J. Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin Liver Dis. 1993 Feb;13(1):50–59. doi: 10.1055/s-2007-1007337. [DOI] [PubMed] [Google Scholar]
  57. de Souza M. S., Smith A. L., Bottomly K. Infection of BALB/cByJ mice with the JHM strain of mouse hepatitis virus alters in vitro splenic T cell proliferation and cytokine production. Lab Anim Sci. 1991 Apr;41(2):99–105. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES